| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/15/2006 | US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060129385 Cholinergic therapy for individuals with learning disabilities |
| 06/15/2006 | US20060128993 Used to treat mood (depression), anxiety (obsessive compulsive disorder), behavioral, eating, substance abuse and sexual disorders and for prevention of migraines; (1S,4R)-N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine |
| 06/15/2006 | US20060128975 Immunosuppressants and apoptosis for cells for anticancer agents |
| 06/15/2006 | US20060128973 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes |
| 06/15/2006 | US20060128972 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 06/15/2006 | US20060128971 Process for the preparation of the amorphous form of atorvastatin calcium salt |
| 06/15/2006 | US20060128965 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid |
| 06/15/2006 | US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists |
| 06/15/2006 | US20060128955 Enantiomorph purity; chromatography |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128814 Photolytic cross-linkable monomers |
| 06/15/2006 | US20060128812 Esterification of 2-[(diphenylmethyl)thio]acetic acid with an acyclic alcohol under reflux in the presence of an acid catalyst; amidation with ammonia; further oxidation with hydrogen peroxide produces Modafinil; central nervous system stimulant; narcolepsy |
| 06/15/2006 | US20060128811 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine |
| 06/15/2006 | US20060128810 Remedies for allergic diseases |
| 06/15/2006 | US20060128809 Rapidly absorbed liquid compositions |
| 06/15/2006 | US20060128808 Method of using adapalene in acne maintenance therapy |
| 06/15/2006 | US20060128807 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 06/15/2006 | US20060128806 Controlled release arginine alpha-ketoglutarate |
| 06/15/2006 | US20060128805 Methods of treating erythropoietin-resistance |
| 06/15/2006 | US20060128804 Novel approach to antimicrobial host defense with molecular shields with EPA and DHA analogs |
| 06/15/2006 | US20060128803 Method of treating dry eye disorders using 13(S)-HODE and its analogs |
| 06/15/2006 | US20060128802 acamprosate; Parkinson's disease or Huntington's disease |
| 06/15/2006 | US20060128801 Organic compounds |
| 06/15/2006 | US20060128800 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 06/15/2006 | US20060128799 Method for preparation of amino acid chelate |
| 06/15/2006 | US20060128798 Method and composition for resuscitation |
| 06/15/2006 | US20060128797 inhibiting cerebrospinal fluid (CSF) production; removing CSF from subarachnoid space; replacing CSF by infusing a lymph-like fluid; artificial CSF is polypeptides (gelatins), ionic magnesium (Mg2+), ATP, and insulin; neuro-cardiopulmonary resuscitation; mild acidosis; Furosemide Acetazolamide |
| 06/15/2006 | US20060128795 Agents for promoting fattening of animals and method of promoting fattening |
| 06/15/2006 | US20060128794 Treatment of interstitial cystitis using (6aR,10aR)-delta8-tetrahydrocannabinol-11-OIC acids |
| 06/15/2006 | US20060128793 -[(Diethylamino)methylene]-7,11-dihydroxy-4-(methoxymethyl)-4a,6a-dimethyl-2,10-dioxo-1,2,4,4a,5,6,6a,7,8,9,9a,10-dodecahydroindeno[4,5-h]isochromen-5-yl acetate; antitumor, -carcinogenic, proliferative agents; imroved antitumor activity; nontoxic; TOR (target of rapamycin) inhibitors |
| 06/15/2006 | US20060128792 Deguelin as a chemopreventive agent for lung cancer |
| 06/15/2006 | US20060128791 3-Methylamino-1-(2-thienyl)-1-propanone, production and use thereof |
| 06/15/2006 | US20060128790 5,7,8-Trimethyl-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-6-ol; also analogous thiochromenes; antiapoptosis; anticarcinogenic agents; antihypoxic agents; anoxia; antiinflamatory agents; central nervous system disorders; autoimmune diseases; neurodegenerative disorders |
| 06/15/2006 | US20060128789 Especially 4-(hydroxymethyl)pyrrolidin-3-ol, forming camphor sultam from camphorsulfonic acid, SO2Cl2 and NH3 or forming diethyl 2-(benzyloxymethoxy)-3-(benzyloxymethyl)succinate from diethyl maleate and benzyl chloromethyl ether as an intermediate |
| 06/15/2006 | US20060128788 Purification of tegaserod maleate |
| 06/15/2006 | US20060128787 Acyl-CoA: cholesterol acyltransferase and lipoxygenase inhibitors; superior oral absorbability; strong antihyperlipidemia effect and an anti-arteriosclerosis effect; N-(5-methanesulfonylamino-4,6-dimethyl-1-propylindolin-7-yl)-2,2-dimethylpropanamide |
| 06/15/2006 | US20060128786 Compounds for the treatment of alzheimer's disease |
| 06/15/2006 | US20060128785 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128783 Tyrosine kinase inhibitors |
| 06/15/2006 | US20060128782 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 06/15/2006 | US20060128781 Flavaxate derivatives as muscarinic receptor antagonists |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128778 Amino acid composition for improving central functions |
| 06/15/2006 | US20060128777 Cancer treatments |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128775 Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl) methyl] benzonitrile |
| 06/15/2006 | US20060128774 Coatings for automotive and architectural structures;coatings cure rapidly with low VOC emissions |
| 06/15/2006 | US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis |
| 06/15/2006 | US20060128771 Method of treating acne |
| 06/15/2006 | US20060128770 Thiazole derivatives |
| 06/15/2006 | US20060128769 Thiazoyl biphenyl amides |
| 06/15/2006 | US20060128768 Furanthiazole derivatives as heparanase inhibitors |
| 06/15/2006 | US20060128767 Methods of preparing sulfinamides and sulfoxides |
| 06/15/2006 | US20060128766 Triazole substituted aminobenzophenone compounds |
| 06/15/2006 | US20060128765 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| 06/15/2006 | US20060128764 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
| 06/15/2006 | US20060128763 Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof |
| 06/15/2006 | US20060128762 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 06/15/2006 | US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors |
| 06/15/2006 | US20060128760 Use of mglur5 antagonists for the treatment of gerd |
| 06/15/2006 | US20060128759 Substituted isoxazole derivatives and their use in pharmaceutics |
| 06/15/2006 | US20060128758 4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128756 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| 06/15/2006 | US20060128755 3'-trifluoromethyl-3,4,5,6-tetrahydro-2H-[1,2']-bipyridinyl-4-carboxylic acid (4-isopropylphenyl)amide; antiinflammatory and analgesic |
| 06/15/2006 | US20060128754 tubulysin derivatives used as antitumor agents |
| 06/15/2006 | US20060128753 4-Aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 06/15/2006 | US20060128752 Chemical compounds |
| 06/15/2006 | US20060128751 CETP inhibitors in combination with antihypertensive agents and uses thereof |
| 06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128748 Bicyclic triazole alpha4 integrin inhibitors |
| 06/15/2006 | US20060128747 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 06/15/2006 | US20060128746 Methods, kits and compositions for using pyrrole derivatives |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128744 Use of 5-HT6 agonist for the treatment and prevention of neurodegenerative disorders |
| 06/15/2006 | US20060128743 Method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs |
| 06/15/2006 | US20060128742 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 06/15/2006 | US20060128741 Such as N,8-Dimethyl-2-(methylthio)-8H-imidazo[4,5-d]thiazolo[4,5-b]pvridin-5-amine; inflammatory and immune diseases; i-kappa-b kinase inhibitors |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128739 Solvent free amorphous rapamycin |
| 06/15/2006 | US20060128738 Treatment of interstitial cystitis using cannabinoid analogs |
| 06/15/2006 | US20060128737 Androgen receptor agonists |
| 06/15/2006 | US20060128736 Camptothecin-carboxylate formulations |
| 06/15/2006 | US20060128735 Substituted thiophenes with antibacterial activity |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128733 Method for treating HIV infection through co-administration of tipranavir and reverset |
| 06/15/2006 | US20060128732 enzyme inhibitor of phosphotidylinositol-3-kinase (PI3K); N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide; antiinflammatory agent, immunomodulators; asthma, dermatitis, rhinitis, allergic diseases, chronic obstructive pulmonary disease, rheumatoid arthritis, Graves' disease |
| 06/15/2006 | US20060128731 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy; N,N-dimethyl-4-(2-furyl)-1H-pyrrolo[2,3- d]pyrimidine-2-amine |
| 06/15/2006 | US20060128730 Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders |
| 06/15/2006 | US20060128729 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 06/15/2006 | US20060128728 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 06/15/2006 | US20060128726 Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulations |
| 06/15/2006 | US20060128725 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/15/2006 | US20060128724 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 06/15/2006 | US20060128723 Sulptionamide compounds that modulate chemokine receptor activity (CCR4) |